Your session is about to expire
← Back to Search
I004 for Pharmacokinetics
Study Summary
This trial is testing whether a proposed biosimilar to NovoLog is equivalent in PK and PD.
- Pharmacodynamics
- Pharmacokinetics
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Does this research project restrict participation to people under a certain age?
"The target age range for participants in this trial are individuals who are 65 years old or younger and have already reached the age of majority."
Are patients who are taking other medications still able to enroll in this research project?
"This trial is seeking 60 patients that fit the pharmacokinetics age range of 18 to 65. Most notably, the patients must meet the following requirements: They must agree to participate and sign an informed consent form. They must be male or female, have a body mass index between 18.5 and 29.9 kg/m2, weigh at least 50 kg, have a fasting plasma glucose level below 100 mg/dL (5.5 mmol/L), have an HbA1c level below 5.7%, not have smoked for at least 3 months prior to screening, and if female, be post-menopausal, surg"
How many people can potentially join this research project?
"That is correct. Currently, the clinicaltrials.gov website is listing this trial as actively recruiting patients. This study was posted on 8/22/2022 and was updated on 9/13/2022. They are looking for a total of 60 participants at 1 location."
Share this study with friends
Copy Link
Messenger